participate in the secondary market for patents. We document 220 assignments, involving a total of 544 U.S. patent assets, that … appear to represent arms-length patent sales by universities (or other nonprofit research institutes) during the period 2012 … are almost entirely absent from the market. We also find that few academic U.S. patent sales bear the hallmarks of …

top 300 universities worldwide. By providing a patent ranking system and an analysis of the determinants of university …

rapid growth in terms of quantity while patent quality did not increase to a similar degree. Regarding the second objective …, we find that a subsidy program to promote research excellence at selected universities is a significant driver of patent … quantity and quality. In contrast, a subsidy program that decreases the costs of patent applications seems to enhance patent …

) “patent-paper pairs” methodology. We use this methodology to identify the scientific publications associated with University … patented academic discoveries, citations to licensed patent-linked publications are higher in the three years after the license …

linkage contributes to the debate on firm- or university-led innovation. Using a large patent dataset from Shenzhen, the first … firms into the university-led innovation clusters in science parks; firm innovation in patent fields like human necessities …

This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed … examination of patent applicants, filing dates, and offices of first and subsequent filing, the paper identifies patterns and …

then, the issue of the relationship between patent protection and the development of and access to medical treatments and … an overview of the patent landscape of medical treatments and technologies related to COVID-19, and of the patent status … of two investigational medical treatments: remdesivir and lopinavir/ritonavir. It then presents various patent …